戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                             Blinded to histopathology, all MRI sequences were consensus s
2 ints; whole mounts and histological specimens were analyzed blinded to treatment.
3  blinded to treatment allocation in the first 12 weeks, and blinded to the dose of bimekizumab thereafter.
4 ent care, but only 2 (7.7%) require that their decisions be blinded to ethically irrelevant considerations.
5 les were taken from predefined standard areas of the brain, blinded to MRI findings.
6 rba-R NxG testing was completed by Cepheid (Sunnyvale, CA), blinded to genotype.
7  = 24; 3 mg, n = 19) once daily for 12 weeks were evaluated blinded to time point, subject, and clinical information.
8 sured at the point-of-care as well as remotely by an expert blinded to all patient details.
9 d complications at 3 months, assessed by wound care experts blinded to the treatment arm and using objective wound assess
10 hen compared the accuracy of predictions of the causal gene blinded to the genetic data using 2 approaches: subjective cl
11                                 Two experts reviewed images blinded to patient outcome.
12 ikely diagnosis, and assessed the activity of inflammation, blinded to clinical findings.
13  studied; images were analyzed by a central core laboratory blinded to clinical and biomarker data.
14                                 Two neurointerventionalists blinded to acquisition protocols were asked to independently
15       The simple criteria were applied by neuropathologists blinded to the prior diagnoses at University of Pennsylvania.
16 nd contralateral homologs were seeded by a neuroradiologist blinded to functional MRI findings.
17                                       Two neuroradiologists blinded to clinical and radiological information analyzed the
18  follow-up period and use of outcome assessors who were not blinded to the group allocation.
19 e read by two certified screening radiologists who were not blinded to the technologists' reading.
20 e primary percutaneous coronary intervention by an operator blinded to Killip classification.
21                                    Autopsies were performed blinded to PET results.
22 onnaire, spirometry and clinical examination by a physician blinded to HTLV-1 status, clinical records and spirometry res
23 y 2017, four fellowship-trained breast imaging radiologists blinded to final histologic findings interpreted DBT examinat
24               Two data sets were scored by two radiologists blinded to all clinical data; data set 1 contained pre- and p
25                                            Two radiologists blinded to clinical information assessed EPE according to sta
26                 CT images were analyzed by two radiologists blinded to the RT-PCR results.
27 me dataset by two experienced musculoskeletal radiologists, blinded to clinical history.
28 c performance and confidence were evaluated for two readers blinded to final diagnosis.
29 T, and CT scans in different reading sessions, with readers blinded to clinical information and other images.
30 re retrospectively assessed by 2 attending breast surgeons, blinded to operator identity, using a video-based assessment
31 tilizing an evidence-based framework, 3 gene curation teams blinded to each other's work scored the level of evidence for
32                                             PSG scoring was blinded to the automatically analyzed WP data.
33  and the pain specialist physician (reference standard) was blinded to the outcome of the initial UNIP evaluation and the
34                                             The surgeon was blinded to the imaging results.
35 l studies were reviewed by an abdominal radiologist who was blinded to the pathological results.
36 ages from CT, whole-body MRI, or bone scintigraphy and were blinded to results with the other modalities.
37        Racial/ethnic and religious minority categories were blinded to preserve anonymity and we accounted for missing da
38                             Investigators and clusters were blinded to randomisation until 2 weeks prior to each step.
39                   Patients and postoperative providers were blinded to allocation.
40                                           Radiologists were blinded to the supine chest radiograph findings during CT int
41                      Both participants and researchers were blinded to treatment allocation in the first 12 weeks, and bl
42                                              Reviewers were blinded to the symptomatic status and MRI scans were analyzed
43                        Echocardiographers at each site were blinded to the treatment allocation.
44                                      Measurement staff were blinded to allocation.
45                                 Participants and staff were blinded to group assignment.
46 ug; participants and other clinical and research staff were blinded to treatment allocation.
47                      Evaluators of cardiac MRI studies were blinded to all clinical information.
48                Neither participants nor the study team were blinded to group allocation.
49 ming the initial assessment with the UNIP (index test) were blinded to the study, and the pain specialist physician (refe
50 y CT and MRI, and images were read by four readers who were blinded to clinical information.